Singapore markets close in 4 hours 23 minutes

Teleflex Incorporated (TFX)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
206.71-4.46 (-2.11%)
At close: 04:00PM EDT
206.71 -0.23 (-0.11%)
After hours: 04:02PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close211.17
Open209.52
Bid0.00 x 1200
Ask0.00 x 800
Day's range205.39 - 209.52
52-week range177.63 - 276.43
Volume337,608
Avg. volume272,251
Market cap9.736B
Beta (5Y monthly)1.12
PE ratio (TTM)27.31
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield1.36 (0.66%)
Ex-dividend date29 Feb 2024
1y target estN/A
All
News
  • GlobeNewswire

    Teleflex Announces First Quarter 2024 Earnings Conference Call Information

    WAYNE, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, May 2, 2024. To participate in the conference call, please utilize this link to pre-register and receive the dial-in information. The call can also be accessed through a live audio webcast on the company’s website, teleflex.com. An audio replay of the call will be availab

  • GlobeNewswire

    Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types

    WAYNE, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the upcoming full market release of the Advanced Tissue Control (ATC) feature on its unified UroLift™ 2 System platform designed for the treatment of benign prostatic hyperplasia (BPH) symptoms in men with all prostate types up to 100g. The UroLift™ 2 System with Advanced Tissue Control (UroLift™ 2 ATC) has received FDA clearance, marking a significa

  • GlobeNewswire

    Teleflex’s Climate Targets Validated by the Science Based Targets Initiative

    Teleflex commits to reach net-zero greenhouse gas emissions across its value chain by 2050.WAYNE, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced its near- and long-term climate change targets have been validated by the Science Based Targets initiative (SBTi). The announcement comes ahead of the company’s release of its 2023 Global Impact Report, which will be published in May 2024. Teleflex has respond